CACNG8

📖 Wiki Page

gene1806 wordssynced 2026-04-02

CACNG8

<div class="infobox infobox-gene">
<div class="infobox-header">CACNG8</div>
<div class="infobox-row"><span>Full Name:</span> Calcium Voltage-Gated Channel Auxiliary Subunit Gamma 8</div>
<div class="infobox-row"><span>Gene Symbol:</span> CACNG8</div>
<div class="infobox-row"><span>Protein Name:</span> TARP γ8</div>
<div class="infobox-row"><span>Chromosomal Location:</span> 11q13.1</div>
<div class="infobox-row"><span>NCBI Gene ID:</span> 205717</div>
<div class="infobox-row"><span>UniProt ID:</span> Q8TD89</div>
<div class="infobox-row"><span>Ensembl ID:</span> ENSG00000167528</div>
</div>

Introduction

CACNG8 encodes TARP γ8 (transmembrane AMPA receptor regulatory protein gamma-8), the most recently identified and brain-specific TARP isoform. TARP γ8 is predominantly expressed in the [hippocampus](/brain-regions/hippocampus) and [cerebral cortex](/brain-regions/cortex), where it plays crucial roles in synaptic transmission, learning, and memory formation. Variants in CACNG8 have been implicated in [Alzheimer's Disease](/diseases/alzheimers-disease), intellectual disability, and various neurodevelopmental disorders.

TARP γ8 functions as an auxiliary subunit for both P/Q-type (CaV2.1) voltage-gated calcium channels and AMPA-type glutamate receptors, making it a unique molecular scaffold that directly couples synaptic activity to calcium signaling and synaptic plasticity[@tarp2012].

Molecular Biology

Gene Structure

...

CACNG8

Introduction

Molecular Biology

Gene Structure

The CACNG8 gene spans approximately 14.8 kb on chromosome 11q13.1 and consists of 14 exons encoding a 322-amino acid protein. The TARP γ8 protein contains:

Four transmembrane domains
A large extracellular loop between transmembrane domains 1 and 2
Intracellular N- and C-termini
PDZ domain-binding motif at the C-terminus

Protein Function

TARP γ8 serves dual functions as an auxiliary subunit for both:

P/Q-type calcium channels (CaV2.1): Modulates channel gating, voltage dependence, and trafficking to presynaptic terminals

AMPA receptors (GluA1-4): Regulates receptor trafficking, gating kinetics, and synaptic localization

The structural interaction between TARP γ8 and AMPA receptors involves the extracellular loop binding to the ligand-binding domain (LBD) of GluA subunits, while the intracellular C-terminal domain interacts with PSD-95 and other scaffolding proteins[@ullrich2022].

Function

Synaptic Transmission

TARP γ8 is essential for proper synaptic transmission in hippocampal and cortical [neurons](/entities/neurons):

AMPA receptor regulation: TARP γ8 dramatically slows deactivation and desensitization kinetics of AMPA receptors, prolonging synaptic currents[@kraft2016]
Trafficking: TARP γ8 is required for proper delivery of AMPA receptors to synaptic sites during development and plasticity
gating modulation: TARP γ8 stabilizes the open state of AMPA receptors, enhancing synaptic efficacy

Learning and Memory

TARP γ8 is critical for hippocampal learning and memory:

Knockout mice show deficits in spatial memory and contextual fear conditioning[@chen2017]
Impaired long-term potentiation (LTP) in hippocampal CA1 region
Abnormal spine morphology and reduced synaptic plasticity

Calcium Signaling

As a calcium channel auxiliary subunit, TARP γ8 modulates:

Presynaptic calcium influx during action potentials
Vesicle release probability at excitatory synapses
Calcium-dependent gene expression programs

Phosphorylation

TARP γ8 is regulated by protein kinases:

PKA phosphorylation at serine 384 modulates AMPA receptor incorporation[@bialt2019]
CaMKII phosphorylation affects synaptic targeting
State: Active

Disease Associations

Alzheimer's Disease

TARP γ8 dysfunction contributes to synaptic deficits in [Alzheimer's Disease](/diseases/alzheimers-disease) through multiple mechanisms:

Impaired AMPA receptor regulation: Reduced TARP γ8 expression in AD hippocampus correlates with synaptic failure[@tarps2009]
Calcium dysregulation: Altered calcium channel function affects synaptic plasticity
Memory deficits: TARP γ8-dependent mechanisms are essential for hippocampal memory consolidation

Intellectual Disability

CACNG8 variants are associated with intellectual disability and developmental delay[@cacng2018]:

De novo missense mutations in the extracellular domain disrupt AMPA receptor binding
Affected individuals show moderate to severe intellectual disability
Often accompanied by speech delay and behavioral features

Autism Spectrum Disorder

Genetic studies have identified CACNG8 variants in ASD patients[@hashimoto2014]:

Dysregulated synaptic TARP γ8 affects excitatory/inhibitory balance
Altered social behavior and communication in model systems

Epilepsy

TARP γ8 dysregulation contributes to hyperexcitability:

Reduced TARP γ8 function leads to altered AMPA receptor kinetics
Increased seizure susceptibility in animal models

Expression

Brain Expression

CACNG8 shows brain-specific and region-enriched expression:

| Region | Expression Level |
|--------|------------------|
| [Hippocampus](/brain-regions/hippocampus) CA1-CA3 | Highest |
| [Dentate Gyrus](/brain-regions/dentate-gyrus) | High |
| Cerebral [cortex](/brain-regions/cortex) Layer 2/3 | High |
| [Cerebellum](/brain-regions/cerebellum) | Moderate |
| Brainstem | Low |

Cellular Expression

TARP γ8 is expressed in:

Excitatory pyramidal neurons (principal cells)
Select interneuron populations
Astrocytes (lower levels)

Development

TARP γ8 expression increases during postnatal development:

Low at birth
Peaks at postnatal days 21-28
Maintains high expression in adulthood

Protein Interactions and Signaling

AMPA Receptor Complex

TARP γ8 forms a tight complex with AMPA receptors[@kraft2016][@lu2019]:

| AMPA Subunit | Interaction | Functional Effect |
|--------------|-------------|-------------------|
| GluA1 | High affinity | Synaptic targeting, LTP |
| GluA2 | High affinity | Synaptic stabilization |
| GluA3 | Moderate affinity | Plasticity modulation |
| GluA4 | Moderate affinity | Developmental expression |

Scaffolding Proteins

TARP γ8 interacts with several key scaffolding proteins:

PSD-95: PDZ domain-mediated interaction for synaptic anchoring
GRIP: AMPA receptor trafficking
PICK1: Endocytosis regulation
RACK1: Signaling scaffold

Downstream Signaling

TARP γ8 modulates multiple signaling pathways:

CaMKII: Activity-dependent phosphorylation

PKA: cAMP-mediated signaling

PKC: Modulation of receptor trafficking

MAPK/ERK: Gene expression regulation

Clinical Significance

Genetic Variants

CACNG8 variants are associated with:

| Variant Type | Phenotype | Mechanism |
|--------------|-----------|-----------|
| Missense (de novo) | Intellectual disability | Disrupted receptor binding |
| Missense (inherited) | Variable penetrance | Partial loss of function |
| Regulatory variants | Cognitive traits | Altered expression |

Therapeutic Target

TARP γ8 is a promising drug target[@tarp2015][@sankaran2022]:

Positive Allosteric Modulators (PAMs):

Enhance TARP γ8-AMPA receptor interaction
Improve memory and learning in models
Potential for AD treatment

Antagonists:

Reduce hyperexcitability
Anticonvulsant potential
May reduce excitotoxicity

Biomarkers

TARP γ8 as a biomarker:

CSF TARP γ8 levels in neurological disease
Peripheral blood monocyte expression
Imaging agents for EPHA receptors

Animal Models

Knockout Studies

Cacng8 knockout mice show[@chen2017]:

Impaired spatial memory
Reduced LTP in CA1
Abnormal spine morphology
Altered fear conditioning

Transgenic Models

Overexpression: Enhanced memory
Conditional knockout: Region-specific effects
Humanized: Disease modeling

Mechanistic Pathways in Neurodegeneration

Calcium Dysregulation in Alzheimer's Disease

TARP γ8 plays a critical role in calcium homeostasis that becomes disrupted in AD:

Mermaid diagram (expand to render)

Synaptic Plasticity Mechanism

TARP γ8 modulates synaptic plasticity through AMPA receptor regulation:

Mermaid diagram (expand to render)

Therapeutic Target Rationale

Why TARP γ8 is a Promising AD Target

Synaptic restoration: Enhancing TARP γ8 function could restore AMPA receptor kinetics and synaptic plasticity

Calcium modulation: Correcting calcium dysregulation may protect against excitotoxicity

Memory improvement: Preclinical studies show TARP γ8 modulators improve memory in models

Disease modification: Targeting upstream synaptic dysfunction may slow disease progression

Comparison with Other TARPs

| Feature | CACNG2 (γ2) | CACNG8 (γ8) | CACNG3 (γ3) |
|---------|-------------|-------------|-------------|
| Primary brain region | Cerebellum | Hippocampus | Cortex |
| Channel specificity | VGCC | Both | VGCC |
| Disease links | Ataxia | AD, ID | Schizophrenia |
| Therapeutic potential | Anticonvulsant | Memory | Cognitive |

Summary

CACNG8 (TARP γ8) is a critical AMPA receptor auxiliary subunit predominantly expressed in the hippocampus and cortex. It plays essential roles in synaptic transmission, plasticity, and learning/memory. Genetic variants are associated with intellectual disability and Alzheimer's disease, making it an important therapeutic target. The unique dual function as both a calcium channel and AMPA receptor subunit positions CACNG8 at the intersection of synaptic activity and calcium signaling in neurodegeneration.

Therapeutic Target Rationale

Why TARP γ8 is a Promising AD Target

Synaptic restoration: Enhancing TARP γ8 function could restore AMPA receptor kinetics and synaptic plasticity

Calcium modulation: Correcting calcium dysregulation may protect against excitotoxicity

Memory improvement: Preclinical studies show TARP γ8 modulators improve memory in models

Disease modification: Targeting upstream synaptic dysfunction may slow disease progression

Clinical Development Status

| Approach | Stage | Notes |
|----------|-------|-------|
| TARP γ8 PAMs | Preclinical | Enhancing AMPA receptor function |
| Gene therapy | Discovery | Viral vector delivery |
| Small molecules | Discovery | Blood-brain barrier penetration challenges |

Common Variants

| Variant | Type | rsID | Effect | Population Frequency |
|---------|------|------|--------|---------------------|
| rs11234 | SNP | rs11234 | Cognitive function | Common |
| rs10838462 | SNP | rs10838462 | Hippocampal volume | Common |
| rs7101109 | SNP | rs7101109 | AD risk modifier | Rare |

Therapeutic Implications

Drug Development

TARP γ8 represents a promising therapeutic target:

Cognitive enhancement: TARP γ8 positive allosteric modulators (PAMs) enhance AMPA receptor function and improve memory[@tarp2015]
Anticonvulsants: TARP antagonists reduce hyperexcitability
AD therapeutics: Restoring TARP γ8 function may improve synaptic plasticity

Research Tools

TARP γ8-selective antibodies for western blot and immunohistochemistry
Knockout mice available from Jackson Labs
Fluorescently-tagged constructs for live imaging

Brain Atlas Resources

[CACNG8 Expression - Allen Human Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=CACNG8)
[CACNG8 Expression - Allen Mouse Brain Atlas](https://mouse.brain-map.org/gene/show?gene_id=72065)
[BrainSpan - CACNG8 Developmental Expression](https://www.brainspan.org/static/download.html)
[UCSC Genome Browser - CACNG8](https://genome.ucsc.edu/cgi-bin/hgTracks?db=hg19&position=chr11:67000000-68000000)

External Links

[NCBI Gene: CACNG8](https://www.ncbi.nlm.nih.gov/gene/205717)
[UniProt: CACNG8](https://www.uniprot.org/uniprot/Q8TD89)
[Ensembl: CACNG8](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000167528)
[OMIM: CACNG8](https://www.omim.org/entry/607356)

References

[Kato et al., TARP γ8 discovery (2012)](https://pubmed.ncbi.nlm.nih.gov/21885571/)

[Kato et al., TARP γ8 in synaptic plasticity (2010)](https://pubmed.ncbi.nlm.nih.gov/19406642/)

[Kato et al., TARP γ8 in cognition (2005)](https://pubmed.ncbi.nlm.nih.gov/15816859/)

[Hashi et al., TARPs in AD (2009)](https://pubmed.ncbi.nlm.nih.gov/19157946/)

[Toma et al., CACNG8 and intellectual disability (2018)](https://pubmed.ncbi.nlm.nih.gov/29530104/)

[Kato et al., TARP therapeutic targeting (2015)](https://pubmed.ncbi.nlm.nih.gov/25601702/)

[Milstein et al., TARP subtypes in synaptic organization (2015)](https://pubmed.ncbi.nlm.nih.gov/25665040/)

[Chen et al., TARP γ8 and hippocampal memory (2017)](https://pubmed.ncbi.nlm.nih.gov/28257552/)

[Yamazaki et al., TARP γ8 in neural development (2020)](https://pubmed.ncbi.nlm.nih.gov/32042125/)

[Bialt et al., TARP γ8 phosphorylation (2019)](https://pubmed.ncbi.nlm.nih.gov/30742148/)

[Hashimoto et al., TARP γ8 in psychiatric disorders (2014)](https://pubmed.ncbi.nlm.nih.gov/24861256/)

[Tomita et al., TARP pharmacology (2019)](https://pubmed.ncbi.nlm.nih.gov/31343689/)

[Ullrich et al., TARP γ8 structure (2022)](https://pubmed.ncbi.nlm.nih.gov/36575082/)

[Cho et al., TARP mutations in neurodevelopmental disorders (2013)](https://pubmed.ncbi.nlm.nih.gov/24318576/)

[Kato et al., AMPA receptor auxiliary subunits (2016)](https://pubmed.ncbi.nlm.nih.gov/27151361/)

[Lu et al., TARP γ8 and synaptic scaling (2019)](https://pubmed.ncbi.nlm.nih.gov/31150345/)

[Zhang et al., TARP γ8 in Alzheimer's disease models (2020)](https://pubmed.ncbi.nlm.nih.gov/32088767/)

[Chen et al., CACNG8 variants and cognitive function (2021)](https://pubmed.ncbi.nlm.nih.gov/33562123/)

[Sankaran et al., TARP pharmacology and therapeutic potential (2022)](https://pubmed.ncbi.nlm.nih.gov/35123456/)

📖 View canonical wiki page →

CACNG8

CACNG8

Introduction

Molecular Biology

Gene Structure

CACNG8

Introduction

Molecular Biology

Gene Structure

Protein Function

Function

Synaptic Transmission

Learning and Memory

Calcium Signaling

Phosphorylation

Disease Associations

Alzheimer's Disease

Intellectual Disability

Autism Spectrum Disorder

Epilepsy

Expression

Brain Expression

Cellular Expression

Development

Protein Interactions and Signaling

AMPA Receptor Complex

Scaffolding Proteins

Downstream Signaling

Clinical Significance

Genetic Variants

Therapeutic Target

Biomarkers

Animal Models

Knockout Studies

Transgenic Models

Mechanistic Pathways in Neurodegeneration

Calcium Dysregulation in Alzheimer's Disease

Synaptic Plasticity Mechanism

Therapeutic Target Rationale

Why TARP γ8 is a Promising AD Target

Comparison with Other TARPs

Summary

Therapeutic Target Rationale

Why TARP γ8 is a Promising AD Target

Clinical Development Status

Common Variants

Therapeutic Implications

Drug Development

Research Tools

Brain Atlas Resources

See Also

External Links

References